1. Genome wide profiling in oral squamous cell carcinoma identifies a four genetic marker signature of prognostic significance
    Vui King Vincent-Chong et al, 2017, PLOS ONE CrossRef
  2. MicroRNA-542-3p inhibits oral squamous cell carcinoma progression by inhibiting ILK/TGF-β1/Smad2/3 signaling
    Bin Qiao et al, 2017, Oncotarget CrossRef

  3. Emodin Reverses the Epithelial–Mesenchymal Transition of Human Endometrial Stromal Cells by Inhibiting ILK/GSK-3β Pathway


    Qiaomei Zheng et al, 2020, Drug Design, Development and Therapy CrossRef
  4. New Perspectives on the Role of Integrin-Linked Kinase (ILK) Signaling in Cancer Metastasis
    Paul C. McDonald et al, 2022, Cancers CrossRef
  5. Monocyte Chemoattractant Protein 1 Promotes VEGF-A Expression in OSCC by Activating ILK and MEK1/2 Signaling and Downregulating miR-29c
    Ming-Yu Lien et al, 2020, Frontiers in Oncology CrossRef
  6. Emodin Inhibits the Epithelial to Mesenchymal Transition of Epithelial Ovarian Cancer Cells via ILK/GSK-3β/Slug Signaling Pathway
    Jingjing Lu et al, 2016, BioMed Research International CrossRef